Helen of Troy (HELE) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
23 Dec, 2025Executive summary
Q4 FY25 net sales declined 0.7% year-over-year to $485.9M, with results at the higher end of the outlook range despite currency headwinds; full-year sales were $1.91B, down 4.9%.
Adjusted EPS for Q4 was $2.33, down from $2.45 last year; GAAP diluted EPS rose 24% to $2.22 due to a $64.6M transitional tax benefit.
Olive & June outperformed expectations, became the #1 nail brand in Target, contributed $23M to Q4 sales, and was acquired for nearly $330M in December 2024.
Project Pegasus restructuring completed, delivering the largest annual savings, improving gross margin, and incurring $60.9M in pre-tax charges.
No formal FY26 guidance provided due to global trade policy uncertainty and macroeconomic volatility; supplier diversification and cost control are key focuses.
Financial highlights
Q4 net sales: $485.9M, down 0.7% YOY; adjusted operating margin: 15.4% (-160 bps YOY); gross margin: 48.6% (-40 bps YOY); adjusted EBITDA margin: 17.4% (-190 bps YOY); adjusted EPS: $2.33 (vs. $2.45 LY); free cash flow: $27.1M.
FY25 net sales: $1.908B, down 4.9% YOY; adjusted operating margin: 13.2%; gross margin: 47.9% (+60 bps YOY); adjusted EBITDA margin: 15.2%; adjusted EPS: $7.17; free cash flow: $83.1M (vs. $269.4M LY).
Q4 net income was $50.9M, up from $42.7M; full-year net income was $123.8M, down from $168.6M.
Net leverage ratio at year-end was 3.0x, reflecting the Olive & June acquisition and share repurchases.
Q4 operating margin dropped to 0.4% due to a $51.5M impairment charge; adjusted operating margin was 15.4%.
Outlook and guidance
No FY26 guidance provided due to global trade policy and tariff uncertainty; outlook will be updated when there is more clarity.
Supplier diversification plan accelerated, targeting 70–80% mitigation of $200M+ tariff impact in FY26 and reducing China exposure to under 20% of COGS by end of FY26.
Q1 FY26 expected to be softer than Q4, with pressure from paused retailer direct imports and international headwinds, especially in China.
Anticipate positive free cash flow for the full year despite challenges.
Cost reduction and cash preservation measures implemented, including capex suspension and expense reductions.
Latest events from Helen of Troy
- Prioritizing high-growth brands, revenue focus, and global expansion to drive long-term value.HELE
28th Annual ICR Conference 20263 Feb 2026 - Sales and earnings fell sharply, prompting lower guidance and continued restructuring.HELE
Q1 20253 Feb 2026 - All proposals passed as the company focuses on brand revitalization and operational transformation.HELE
AGM 202423 Jan 2026 - Q2 sales and margins fell, but guidance, cash flow, and $500M buyback remain on track.HELE
Q2 202519 Jan 2026 - $240M acquisition of a high-growth nail brand, immediately accretive and diversifying the portfolio.HELE
M&A Announcement12 Jan 2026 - Sales fell 3.4% as Home & Outdoor grew and Beauty & Wellness declined; guidance narrowed.HELE
Q3 202510 Jan 2026 - Brand revitalization, strategic acquisition, and operational efficiency drive growth and margin gains.HELE
27th Annual ICR Conference 202510 Jan 2026 - Q3 FY2026 net loss and margin pressure driven by asset impairments and tariff headwinds.HELE
Q3 20268 Jan 2026 - Shareholders to vote on board, compensation, new stock plan, and auditor amid growth strategy launch.HELE
Proxy Filing1 Dec 2025